Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

4:01pm EDT
Change (% chg)

$0.02 (+0.67%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ENZ.N


Enzo Biochem, Inc, (Enzo) is a life sciences and biotechnology company. The Company focuses on harnessing biological processes to develop research tools, diagnostics and therapeutics and provides esoteric and other test services to the medical community. The Company’s business is organized as three operating segments: Clinical... (more)


Beta: 2.03
Market Cap(Mil.): $135.21
Shares Outstanding(Mil.): 45.37
Dividend: --
Yield (%): --


  ENZ.N Industry Sector
P/E (TTM): -- 25.18 40.89
EPS (TTM): -0.26 -- --
ROI: -32.73 7.10 15.96
ROE: -34.13 21.07 16.81
Search Stocks

Federal Circuit tosses jury award for Enzo Biochem

NEW YORK - A federal appeals court Monday threw out a nearly $49 million jury award for Enzo Biochem Inc, saying a lower court judge's interpretation of the company's patent was incorrect.

16 Mar 2015

BRIEF-Patent verdict favoring Enzo Biochem is reversed by US appeals court

March 16 - Enzo Biochem Inc : * U.S. appeals court rules in favor of applera corp and against Enzo Biochem

16 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks